A multicentre, randomised, controlled trial to assess the safety, ease of use, and reliability of hyaluronic acid/carboxymethylcellulose powder adhesion barrier versus no barrier in colorectal laparoscopic surgery

作者：Berdah Stephane V^*; Mariette Christophe; Denet Christine; Panis Yves; Laurent Christophe; Cotte Eddy; Huten Noeel; Feuillet Eliane Le Peillet; Duron Jean Jacques

来源：Trials, 2014, 15(1): 413.

DOI：10.1186/1745-6215-15-413

• Adhesion barrier
• Colorectal surgery
• Laparoscopy
• Surgical adhesions
• Surgical site infection

Background: Intra-peritoneal adhesions are frequent following abdominal surgery and are the most common cause of small bowel obstructions. A hyaluronic acid/carboxymethylcellulose (HA/CMC) film adhesion barrier has been shown to reduce adhesion formation in abdominal surgery. An HA/CMC powder formulation was developed for application during laparoscopic procedures. %26lt;br%26gt;Methods: This was an exploratory, prospective, randomised, single-blind, parallel-group, Phase IIIb, multicentre study conducted at 15 hospitals in France to assess the safety of HA/CMC powder versus no adhesion barrier following laparoscopic colorectal surgery. Subjects %26gt;= 18 years of age who were scheduled for colorectal laparoscopy (Mangram contamination class I. III) within 8 weeks of selection were eligible, regardless of aetiology. Participants were randomised 1: 1 to the HA/CMC powder or no adhesion barrier group using a centralised randomisation list. Patients assigned to HA/CMC powder received a single application of 1 to 10 g on adhesion-prone areas. In the no adhesion barrier group, no adhesion barrier or placebo was applied. The primary safety assessments were the incidence of adverse events, serious adverse events, and surgical site infections (SSIs) for 30 days following surgery. Between-group comparisons were made using Fisher%26apos;s exact test. %26lt;br%26gt;Results: Of those randomised to the HA/CMC powder (n = 105) or no adhesion barrier (n = 104) groups, one patient in each group discontinued prior to the study end (one death in each group). Adverse events were more frequent in the HA/CMC powder group versus the no adhesion barrier group (63% vs. 39%; P %26lt; 0.001), as were serious adverse events (28% vs. 11%; P %26lt; 0.001). There were no statistically significant differences between the HA/CMC powder group and the no adhesion barrier group in SSIs (21% vs. 14%; P = 0.216) and serious SSIs (12% vs. 9%; P = 0.38), or in the most frequent serious SSIs of pelvic abscess (5% and 2%; significance not tested), anastomotic fistula (3% and 4%), and peritonitis (2% and 3%). %26lt;br%26gt;Conclusions: This exploratory study found significantly higher rates of adverse events and serious adverse events in the HA/CMC powder group compared with the no adhesion barrier group in laparoscopic colorectal resection.

• 出版日期2014-10-27